229 related articles for article (PubMed ID: 33945606)
1. BCOR gene alterations in hematologic diseases.
Sportoletti P; Sorcini D; Falini B
Blood; 2021 Dec; 138(24):2455-2468. PubMed ID: 33945606
[TBL] [Abstract][Full Text] [Related]
2. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
[TBL] [Abstract][Full Text] [Related]
3. A rare genotype of biallelic mosaic variants in BCOR gene causing a bilateral ocular anterior segment dysgenesis and cataracts.
Mezad-Koursh D; Rosenfeld E; Bachar Zipori A; Zur D; Elhanan E; Ben-Shachar S
Eur J Hum Genet; 2023 Jan; 31(1):125-127. PubMed ID: 36261622
[TBL] [Abstract][Full Text] [Related]
4. Ocular severe involvement in oculofaciocardiodental syndrome: Description of a case series.
Moleiro AF; Oliveira JS; Grangeia A; Faria P; Falcão-Reis F; Magalhães A; Silva SE
Eur J Ophthalmol; 2024 Jan; 34(1):NP6-NP11. PubMed ID: 37157789
[TBL] [Abstract][Full Text] [Related]
5. BCOR/BCORL1 mutated hypergranular cells mimicking acute promyelocytic leukemia.
Lebecque B; Dannus LT
Blood; 2023 May; 141(18):2283. PubMed ID: 37140950
[No Abstract] [Full Text] [Related]
6. TdT-positive high-grade B-cell lymphoma with BCOR and IDH1 mutations.
Yu YT; Lin KY; Chen YP; Chen YL; Medeiros LJ; Chang KC
Pathology; 2023 Dec; 55(7):1038-1040. PubMed ID: 37544875
[No Abstract] [Full Text] [Related]
7. Oculofaciocardiodental syndrome caused by a novel BCOR variant.
Yamashita T; Hotta J; Jogu Y; Sakai E; Ono C; Bamba H; Suzuki H; Yamada M; Takenouchi T; Kosaki K; Yorifuji T; Hamazaki T; Seto T
Hum Genome Var; 2023 Jun; 10(1):18. PubMed ID: 37308473
[TBL] [Abstract][Full Text] [Related]
8. Is Neuroradiology Complementary to Histopathology in Central Nervous System Tumors with an Alteration of the BCOR Gene?
Nikoghosyan A; Sciot R; Jacobs SA; Verhaaren BFJ
Clin Neuroradiol; 2023 Dec; ():. PubMed ID: 38129591
[No Abstract] [Full Text] [Related]
9. Drug Design and Development for Rare Hematologic Diseases.
Fattizzo B; Capecchi M; Motta I
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895940
[TBL] [Abstract][Full Text] [Related]
10. Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B
N Engl J Med; 2021 May; 384(19):1810-1823. PubMed ID: 33979489
[TBL] [Abstract][Full Text] [Related]
11. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia.
Wang F; Morita K; DiNardo CD; Furudate K; Tanaka T; Yan Y; Patel KP; MacBeth KJ; Wu B; Liu G; Frattini M; Matthews JA; Little LD; Gumbs C; Song X; Zhang J; Thompson EJ; Kadia TM; Garcia-Manero G; Jabbour E; Ravandi F; Bhalla KN; Konopleva M; Kantarjian HM; Andrew Futreal P; Takahashi K
Nat Commun; 2021 May; 12(1):2607. PubMed ID: 33972549
[TBL] [Abstract][Full Text] [Related]
12. A stony coral cell atlas illuminates the molecular and cellular basis of coral symbiosis, calcification, and immunity.
Levy S; Elek A; Grau-Bové X; Menéndez-Bravo S; Iglesias M; Tanay A; Mass T; Sebé-Pedrós A
Cell; 2021 May; 184(11):2973-2987.e18. PubMed ID: 33945788
[TBL] [Abstract][Full Text] [Related]
13. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Marcault C; Zhao LP; Maslah N; Verger E; Daltro de Oliveira R; Soret-Dulphy J; Cazaux M; Gauthier N; Roux B; Clappier E; Parquet N; Dosquet C; Réa D; Zini JM; Vainchenker W; Raffoux E; Giraudier S; Kiladjian JJ; Cassinat B; Benajiba L
Blood; 2021 Nov; 138(21):2142-2148. PubMed ID: 33945619
[No Abstract] [Full Text] [Related]
14. DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells.
Lim JY; Duttke SH; Baker TS; Lee J; Gambino KJ; Venturini NJ; Ho JSY; Zheng S; Fstkchyan YS; Pillai V; Fajgenbaum DC; Marazzi I; Benner C; Byun M
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33970190
[TBL] [Abstract][Full Text] [Related]
15. Two competing mechanisms of DNMT3A recruitment regulate the dynamics of de novo DNA methylation at PRC1-targeted CpG islands.
Weinberg DN; Rosenbaum P; Chen X; Barrows D; Horth C; Marunde MR; Popova IK; Gillespie ZB; Keogh MC; Lu C; Majewski J; Allis CD
Nat Genet; 2021 Jun; 53(6):794-800. PubMed ID: 33986537
[TBL] [Abstract][Full Text] [Related]
16. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Huttlin EL; Bruckner RJ; Navarrete-Perea J; Cannon JR; Baltier K; Gebreab F; Gygi MP; Thornock A; Zarraga G; Tam S; Szpyt J; Gassaway BM; Panov A; Parzen H; Fu S; Golbazi A; Maenpaa E; Stricker K; Guha Thakurta S; Zhang T; Rad R; Pan J; Nusinow DP; Paulo JA; Schweppe DK; Vaites LP; Harper JW; Gygi SP
Cell; 2021 May; 184(11):3022-3040.e28. PubMed ID: 33961781
[TBL] [Abstract][Full Text] [Related]
17. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.
Malcikova J; Pavlova S; Kunt Vonkova B; Radova L; Plevova K; Kotaskova J; Pal K; Dvorackova B; Zenatova M; Hynst J; Ondrouskova E; Panovska A; Brychtova Y; Zavacka K; Tichy B; Tom N; Mayer J; Doubek M; Pospisilova S
Blood; 2021 Dec; 138(25):2670-2685. PubMed ID: 33945616
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML.
Tsai CH; Tang JL; Tien FM; Kuo YY; Wu DC; Lin CC; Tseng MH; Peng YL; Hou MF; Chuang YK; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
Blood Adv; 2021 May; 5(10):2456-2466. PubMed ID: 33999144
[TBL] [Abstract][Full Text] [Related]
19. Iterative tomography with digital adaptive optics permits hour-long intravital observation of 3D subcellular dynamics at millisecond scale.
Wu J; Lu Z; Jiang D; Guo Y; Qiao H; Zhang Y; Zhu T; Cai Y; Zhang X; Zhanghao K; Xie H; Yan T; Zhang G; Li X; Jiang Z; Lin X; Fang L; Zhou B; Xi P; Fan J; Yu L; Dai Q
Cell; 2021 Jun; 184(12):3318-3332.e17. PubMed ID: 34038702
[TBL] [Abstract][Full Text] [Related]
20. A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease.
Li J; Wang C; Liu J; Yu Y; Liu Y; Peng Q; Liu H; Guan X
Mol Biol Rep; 2021 Apr; 48(4):3785-3798. PubMed ID: 33987748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
